Author

Zeng Song

Convalife (China)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Chunyan Wang· 1 shared Hao HuangiD· 1 shared Jinwen HuangiD· 1 shared Junfang Pan· 1 shared Liang CaoiD· 1 shared Xiaobing CheniD· 1 shared Xiaokun SheniD· 1 shared Zhongyuan LiiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Chunyan Wang

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A Novel Bispecific Antibody CVL006 Superior to AK112 for Dual Targeting of PD-L1 and VEGF in Cancer Therapy

Chunyan Wang, Hao Huang, Zeng Song, Zhongyuan Li, Jinwen Huang, Liang Cao, Ziai Wu, Junfang Pan, Xiaobing Chen, Xiaokun Shen

This paper develops a bispecific antibody CVL006 that targets PD-L1 and VEGF, showing superior antitumor efficacy compared to existing therapies in preclinical models.

Antibody Therapeutics · May 21, 2025Peer-reviewedPharmacology & Toxicology